Showing results (4981-4990 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|May 26, 2019
Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort StudyMing-Da Wang, Chao Li, Jun Li, et al.The Oncologist|May 10, 2019
Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702)Megumi Furuta, Jun Sakakibara-Konishi, Hajime Kikuchi, et al.The Oncologist|May 11, 2019
Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP ChemotherapyIan W Flinn, Jack Erter, Davey B Daniel, et al.The Oncologist|May 1, 2019
Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and SunitinibJae-Joon Kim, Min-Hee Ryu, Changhoon Yoo, et al.The Oncologist|March 25, 2018
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced CancerGordana Vlahovic, Kellen L Meadows, Ace J Hatch, et al.The Oncologist|November 18, 2017
Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?Dhanusha Sabanathan, John J Park, Manuel Marquez, et al.The Oncologist|November 8, 2019
Brain Metastases from Biliary Tract Cancers: A Case Series and Review of the Literature in the Genomic EraMegan R D'Andrea, Corey M Gill, Melissa Umphlett, et al.The Oncologist|December 20, 2019
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine CarcinomasMing-Huang Chen, Wen-Chi Chou, Chin-Fu Hsiao, et al.The Oncologist|May 17, 2022
Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603Yasuyuki Kawamoto, Satoshi Yuki, Kentaro Sawada, et al.Pageof 571